### [2007-08-6](/news/2007/08/6/index.md)

#  The United States Food and Drug Administration approves Pfizer's AIDS drug Selzentry. 




### Source:

1. [Reuters via National Post](http://www.canada.com/nationalpost/financialpost/story.html?id=0fc48006-5e42-42c2-b6aa-ac629c3254e4&k=26234)

### Related:

1. [ A research team led by an evolutionary biologist at the University of Arizona publishes a paper in ''Nature'' on the genetic history of HIV proving that Gaetan Dugas, the Canadian flight attendant who had been identified for years as "Patient Zero" of the AIDS epidemic in the U.S., did not spread the virus to the country. The study indicates that HIV first spread to the U.S. from the Caribbean around 1970. ](/news/2016/10/26/a-research-team-led-by-an-evolutionary-biologist-at-the-university-of-arizona-publishes-a-paper-in-nature-on-the-genetic-history-of-hiv.md) _Context: AIDS_
2. [Pfizer Inc. decides to terminate its $160 billion merger with Allergan, Plc as officials in Washington crack down on corporate inversions. Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal. ](/news/2016/04/5/pfizer-inc-decides-to-terminate-its-160-billion-merger-with-allergan-plc-as-officials-in-washington-crack-down-on-corporate-inversions-p.md) _Context: Pfizer Inc._
3. [The U.S. Treasury Department announces new regulations to curb tax-avoiding corporate inversions, i.e., where U.S. companies slash their tax bills by claiming a new tax home overseas, though their core operations and management remain in the United States. The pending $160 billion merger of Pfizer Inc. and Allergan, Plc could be cancelled because of these new rules. ](/news/2016/04/4/the-u-s-treasury-department-announces-new-regulations-to-curb-tax-avoiding-corporate-inversions-i-e-where-u-s-companies-slash-their-tax.md) _Context: Pfizer Inc._
4. [Turing Pharmaceuticals says that it is looking for a new CEO in the aftermath of the indictment of its old boss, Martin Shkreli, on securities fraud charges. Turing and Shkreli became infamous together in September 2015, when they hiked the price of an AIDS drug by 5000%. ](/news/2015/12/22/turing-pharmaceuticals-says-that-it-is-looking-for-a-new-ceo-in-the-aftermath-of-the-indictment-of-its-old-boss-martin-shkreli-on-securiti.md) _Context: AIDS_
5. [American pharmaceutical companies Pfizer and Allergan, Plc announce plans to merge to form the world's largest drug company. The merger is subject to approval from regulators in the U.S., European Union and elsewhere as well as approval by shareholders of both companies. If approved, the deal will reduce tax revenue paid to the U.S. by approximately $930 million.  ](/news/2015/11/23/american-pharmaceutical-companies-pfizer-and-allergan-plc-announce-plans-to-merge-to-form-the-world-s-largest-drug-company-the-merger-is-s.md) _Context: Pfizer Inc._
6. [The Obama Administration through the U.S. Treasury Department will clamp down further on corporate income tax-avoiding inversion deals by U.S. companies with foreign rivals. There is a pending inversion deal between U.S. drug maker Pfizer Inc. and smaller Irish competitor Allergan, Plc. ](/news/2015/11/18/the-obama-administration-through-the-u-s-treasury-department-will-clamp-down-further-on-corporate-income-tax-avoiding-inversion-deals-by-u.md) _Context: Pfizer Inc._
7. [American pharmaceutical company Pfizer announces plans to acquire Hospira at a cost of $17 billion. ](/news/2015/02/5/american-pharmaceutical-company-pfizer-announces-plans-to-acquire-hospira-at-a-cost-of-17-billion.md) _Context: Pfizer Inc._
8. [Pfizer announces plans to release an over-the-counter version of heartburn medication Nexium. ](/news/2014/05/27/pfizer-announces-plans-to-release-an-over-the-counter-version-of-heartburn-medication-nexium.md) _Context: Pfizer Inc._
9. [Drugmaker Pfizer says it will not proceed with its attempted $119 billion bid for AstraZeneca. ](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.md) _Context: Pfizer Inc._
10. [AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion.  ](/news/2014/05/19/astrazeneca-rejects-the-latest-and-likely-the-last-takeover-price-from-pfizer-close-to-70-billion-pounds-or-us-118-billion.md) _Context: Pfizer Inc._
